Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Receivables - Net (2012 - 2026)

Updated

Analysis

Grace Therapeutics (GRCE) Receivables - Net (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 20,000.00
Jun 30, 2026 20,000.00
Mar 31, 2026 20,000.00
Dec 31, 2025 20,000.00
Sep 30, 2025 20,000.00
Jun 30, 2025 20,000.00
Mar 31, 2025 126,000.00
Dec 31, 2024 301,000.00
Sep 30, 2024 415,000.00
Jun 30, 2024 398,000.00
Mar 31, 2024 722,000.00
Dec 31, 2023 959,000.00
Sep 30, 2023 837,000.00
Jun 30, 2023 837,000.00
Mar 31, 2023 802,000.00
Dec 31, 2022 778,000.00
Sep 30, 2022 859,000.00
Jun 30, 2022 964,000.00
Mar 31, 2022 548,000.00
Dec 31, 2021 238,000.00
API Access

Grace Therapeutics Receivables - Net API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-net&ticker=GRCE&period=max&api_key=YOUR_API_KEY